ONCOLOGIA E INMUNOLOGIA MOLECULAR
ONCO-INMUNOLOGIA MOLECULAR
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (4)
2022
-
Editorial: Engineered immune cells in cancer immunotherapy (EICCI)
Frontiers in Immunology
2020
1996
-
Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients
Clinical and Experimental Immunology, Vol. 104, Núm. 1, pp. 72-79
1992
-
T cell lines characterize events in the pathogenesis of the wiskott-aldrich syndrome
Journal of Experimental Medicine, Vol. 176, Núm. 3, pp. 867-874